This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Neurological Correlates and Clinical Implications

Steven Kugler, MD; Brenda Anderson, RNC; Dewitt Cross, MD; Zafar Sharif, MD; Mary Sano, PhD; Rita Haggerty, PhD; Isak Prohovnik, PhD; Anne Hurlet-Jensen, MD; Sadek Hilal, MD, PhD; Jay P. Mohr, MD; Darryl C. De Vivo, MD

Arch Neurol. 1993;50(6):629-635.

Abstract
• Objective.
—Eight asymptomatic patients with sickle-cell disease (SCD) with magnetic resonance imaging (MRI) abnormalities consistent with cerebral infarcts (group 1) and eight asymptomatic patients with SCD with normal MRI scans (group 2) were followed up to assess the neurological correlates and the clinical outcome.

Design.
—Patients in the two cohorts underwent clinical evaluations and xenon 133 regional cerebral blood flow (rCBF) studies within 1 month of the entry MRI. This study sequence was repeated up to 5 years later. Neuropsychological studies also were performed in six group 1 patients and eight group 2 patients at the end of the study.

Setting.
—The patients were recruited from the Comprehensive Sickle Cell Center at Columbia University, New York, NY.

Patients.
—All patients had SCD, hemoglobin SS, and normal findings on clinical evaluation at entry. The group 1 cohort had clinically silent MRI abnormalities consistent with cerebral infarction. The group 2 cohort was age matched to group 1 and had normal MRI studies.

Interventions.
—None.

Main Outcome Measure.
—The natural history of MRI abnormalities and the neurological correlates were assessed to determine the predictive value of subclinical MRI lesions as a risk factor for clinically apparent stroke.

Results.
—The mean duration of MRI follow-up was 3.7 years. In group 1, four patients (50%) demonstrated progressive MRI abnormalities and three patients (38%) became clinically symptomatic. In group 2, findings for all patients remained normal on clinical and radiological examination. Both groups had markedly elevated rCBF values. Individual rCBF differences correlated with the specific MRI abnormalities. The psychometric study results were similar in the two cohorts. Eighty-three percent of group 1 and 88% of group 2 patients had defective scores in one or more areas of cognitive functioning. Three patients met cognitive criteria for dementia.

Conclusions.
—Cranial MRI abnormalities have important prognostic implications even when detected in clinically asymptomatic patients. Cognitive abnormalities exist in patients with SCD even in the absence of MRI abnormalities or clinical stroke.

Author Affiliations
From the Departments of Neurology (Drs Kugler, Mohr, and De Vivo and Ms Anderson), Pediatrics (Drs Kugler, Hurlet-Jensen, and De Vivo and Ms Anderson), Radiology (Drs Cross and Hilal), Psychiatry (Drs Sharif and Prohovnik), and Psychology (Drs Sano and Haggerty), College of Physicians and Surgeons of Columbia University and the Presbyterian Hospital, New York, NY.

Footnotes
Accepted for publication October 6, 1992.

Presented in part at the 20th Child Neurology Society Meeting, Portland, Ore, October 1991.

Reprint requests to The New York Neurological Institute, 710W 168th St, New York, NY 10032 (Dr De Vivo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebral Blood Flow Measurement in Children With Sickle Cell Disease Using Continuous Arterial Spin Labeling at 3.0-Tesla MRI
van den Tweel et al.
Stroke 2009;40:795-800.
ABSTRACT | FULL TEXT  

Radiographic Predictors of Neurocognitive Functioning in Pediatric Sickle Cell Disease
Kral et al.
J Child Neurol 2006;21:37-44.
ABSTRACT  

Cognitive Deficits in Children With Sickle Cell Disease
Steen et al.
J Child Neurol 2005;20:102-107.
ABSTRACT  

Transcranial Doppler Ultrasonography and Executive Dysfunction in Children with Sickle Cell Disease
Kral and Brown
J Pediatr Psychol 2004;29:185-195.
ABSTRACT | FULL TEXT  

Relationship of Structural Magnetic Resonance Imaging, Magnetic Resonance Perfusion, and Other Disease Factors to Neuropsychological Outcome in Sickle Cell Disease
Grueneich et al.
J Pediatr Psychol 2004;29:83-92.
ABSTRACT | FULL TEXT  

Transcranial Doppler Ultrasonography and Neurocognitive Functioning in Children With Sickle Cell Disease
Kral et al.
Pediatrics 2003;112:324-331.
ABSTRACT | FULL TEXT  

Cognitive Impairment in Children with Hemoglobin SS Sickle Cell Disease: Relationship to MR Imaging Findings and Hematocrit
Steen et al.
Am. J. Neuroradiol. 2003;24:382-389.
ABSTRACT | FULL TEXT  

Cognitive Functioning in Children With Sickle Cell Disease: A Meta-Analysis
Schatz et al.
J Pediatr Psychol 2002;27:739-748.
ABSTRACT | FULL TEXT  

Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease
Pegelow et al.
Blood 2002;99:3014-3018.
ABSTRACT | FULL TEXT  

Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Pegelow et al.
Arch Neurol 2001;58:2017-2021.
ABSTRACT | FULL TEXT  

Implementation of the STOP Protocol for Stroke Prevention in Sickle Cell Anemia by Using Duplex Power Doppler Imaging
Malouf et al.
Radiology 2001;219:359-365.
ABSTRACT | FULL TEXT  

Sickle Cell and the Brain
Adams et al.
ASH Education Book 2001;2001:31-46.
ABSTRACT | FULL TEXT  

Risk Factors for Arterial Ischemic Stroke in Children
Kirkham et al.
J Child Neurol 2000;15:299-307.
ABSTRACT  

Sickle Cell Disease and Stroke
Adams
J Child Neurol 1995;10:75-76.